The Correlation between Inflammation, BPH and Prostate CancerDJAVAN, Bob.European urology. Supplement. 2009, Vol 8, Num 13, issn 1569-9056, 37 p.Serial Issue

Lower urinary tract symptoms/benign prostatic hyperplasia: Fast control of the patient's quality of lifeDJAVAN, Bob.Urology (Ridgewood, NJ). 2003, Vol 62, Num 3A, pp 6-14, issn 0090-4295, 9 p.Conference Paper

Prostate cancer update: advances in disease management over the past 20 yearsFITZPATRICK, John; DJAVAN, Bob.BJU international. Supplement (Print). 2007, Vol 100, Num 2, issn 1465-5101, 65 p.Serial Issue

Lower urinary tract symptoms/benign prostatic hyperplasia: controlling factors that matterCHAPPLE, Christopher R; DJAVAN, Bob.Urology (Ridgewood, NJ). 2003, Vol 62, Num 3A, issn 0090-4295, 43 p.Conference Proceedings

Biopsy standards for detection of prostate cancer : Treatment of localized prostate cancerDJAVAN, Bob; MARGREITER, Markus.World journal of urology (Print). 2007, Vol 25, Num 1, pp 11-17, issn 0724-4983, 7 p.Article

Serenoa repens: The Scientific Basis for the Treatment of Benign Prostatic HyperplasiaHABIB, Fouad K.European urology. Supplement. 2009, Vol 8, Num 13, pp 887-893, issn 1569-9056, 7 p.Article

The Role of Serenoa repens in the Clinical Management of Lower Urinary Tract Symptoms Due to Benign Prostatic HyperplasiaLOWE, Franklin C.European urology. Supplement. 2009, Vol 8, Num 13, pp 894-897, issn 1569-9056, 4 p.Article

Is the era of prostate-specific antigen over?DJAVAN, Bob; ROCCO, Bernardo; STANGELBERGER, Anton et al.BJU international. Supplement (Print). 2007, Vol 100, Num 2, pp 8-10, issn 1465-5101, 3 p.Article

Molecular aspects of hormone-independent prostate cancerSCHALKEN, Jack A.BJU international. Supplement (Print). 2007, Vol 100, Num 2, pp 52-55, issn 1465-5101, 4 p.Article

Insulin-like growth factors and prostate cancerDJAVAN, Bob; WALDERT, Matthias; SEITZ, Christian et al.World journal of urology (Print). 2001, Vol 19, Num 4, pp 225-233, issn 0724-4983Article

Prostate cancer screening markersSTANGELBERGER, Anton; MARGREITER, Markus; SEITZ, Christian et al.The journal of men's health & gender. 2007, Vol 4, Num 3, pp 233-244, issn 1571-8913, 12 p.Article

Chemotherapy of premalignant lesions : new insightsRAVERY, Vincent.BJU international. Supplement (Print). 2007, Vol 100, Num 2, pp 18-21, issn 1465-5101, 4 p.Article

Multiple intracrine hormonal targets in the prostate : opportunities and challengesLABRIE, Fernand.BJU international. Supplement (Print). 2007, Vol 100, Num 2, pp 48-51, issn 1465-5101, 4 p.Article

Lower urinary tract symptoms suggestive of benign prostatic hyperplasia : latest update on α₁-adrenoceptor antaqonistsMILANI, Shirin; DJAVAN, Bob.BJU international. Supplement (Print). 2005, Vol 95, Num 4, pp 29-36, issn 1465-5101, 8 p.Article

State of the art on the efficacy and tolerability of alpha₁-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasiaDJAVAN, Bob; CHAPPLE, Chris; MILANI, Shirin et al.Urology (Ridgewood, NJ). 2004, Vol 64, Num 6, pp 1081-1088, issn 0090-4295, 8 p.Article

Current prostate cancer : 20 years laterMARBERGER, Michael.BJU international. Supplement (Print). 2007, Vol 100, Num 2, pp 11-14, issn 1465-5101, 4 p.Article

Artificial Neural Networks for decision-making in Urologic oncologyANAGNOSTOU, Theodore; REMZI, Mesut; LYKOURINAS, Michael et al.European urology. 2003, Vol 43, Num 6, pp 596-603, issn 0302-2838, 8 p.Article

Active surveillance vs radical prostatectomyABRAHAMSSON, Per-Anders.BJU international. Supplement (Print). 2007, Vol 100, Num 2, pp 26-28, issn 1465-5101, 3 p.Article

Hormone-refractory prostate cancer : what have we learned?WIRTH, Manfred P.BJU international. Supplement (Print). 2007, Vol 100, Num 2, pp 56-59, issn 1465-5101, 4 p.Article

Lower urinary tract symptoms/benign prostatic hyperplasia: Maintaining symptom control and reducing complicationsO'LEARY, Michael P.Urology (Ridgewood, NJ). 2003, Vol 62, Num 3A, pp 15-23, issn 0090-4295, 9 p.Conference Paper

The use of α₁-adrenoceptor antagonists in lower urinary tract symptoms: Beyond benign prostatic hyperplasiaNICKEL, J. Curtis.Urology (Ridgewood, NJ). 2003, Vol 62, Num 3A, pp 34-41, issn 0090-4295, 8 p.Conference Paper

Chemoprevention of prostate cancer : lessons learnedTHOMPSON, Ian M.BJU international. Supplement (Print). 2007, Vol 100, Num 2, pp 15-17, issn 1465-5101, 3 p.Article

Luteinizing hormone-releasing hormone analogues and hormone ablation for prostate cancer : state of the artSCHALLY, Andrew V.BJU international. Supplement (Print). 2007, Vol 100, Num 2, pp 2-4, issn 1465-5101, 3 p.Article

How to preserve potency and continence in localized prostate cancerBREDA, Guglielmo; CELIA, Antonio.BJU international. Supplement (Print). 2007, Vol 100, Num 2, pp 29-31, issn 1465-5101, 3 p.Article

Is hormone ablation still the right choice for advanced prostate cancer?FITZPATRICK, John M.BJU international. Supplement (Print). 2007, Vol 100, Num 2, pp 36-39, issn 1465-5101, 4 p.Article